2
through the skull bone. Transcranial Color Doppler (TCCD)
Ultrasound thus provides low-resolution images, where only
the proximal segments of the cerebral basal arteries (circle of
Willis and afferent arteries) can be depicted [6].
Increasing the sensitivity of ultrasound to blood flow has been
an extensive field of research over the last 20 years [7],
entailing ultrasonic probe developments, modification of the
ultrasonic emission schemes [8], and refining of the signal
processing chain [9]. An interesting setting for ultrasensitive
blood flow imaging combines Ultrafast imaging and
spatiotemporal Singular Value Decomposition (SVD) [10],
with proven efficiency for cerebrovascular imaging [11].
More recently, ultrafast imaging combined with a contrast
agent was proved able to beat by almost two orders of
magnitude the resolution limit of conventional Ultrasound, a
technique named Ultrasound Localization Microscopy (ULM)
[12]–[15]. Inspired by super resolution optical microscopy
techniques [16], the idea is to use microbubbles, a widely used
ultrasound contrast agent, as strong point-like scatterers
distributed in the vasculature [17], [18]. These microbubbles
indeed have a typical 2-3 µm mean diameter but are yet very
echogenic thanks to the large acoustic impedance mismatch
between gas and liquid. Imaged by ultrasound at thousands of
frames per second, they can thus be individually localized and
followed in time from one frame to the next, providing
vasculature maps resolving structures as small as 9 µm, highly
surpassing the ultrasound diffraction limit.
If these methods have successfully been used in rodents,
their translation to the clinic remains challenging, due to the
much higher imaging depth required, and the huge obstacle of
the skull bone. Bones indeed exhibit much higher density
( ) and sound speed
( ) than soft tissues such as skin,
muscle, or brain ( ,
), which leads to a high acoustic
impedance mismatch and poor acoustic transmission at the
skin/bone and bone/dura mater interfaces. Furthermore, the
acoustic attenuation coefficient inside the skull bone is one of
the highest in the human body (~30 dB/cm at 2 MHz), which
means that imaging is only feasible through the thinnest point,
the temporal window. Finally, the skull biases the image
reconstruction by modifying the speed of sound on a section
of the propagation medium, and the spatial heterogeneities of
the skull bone width and sound speed lead to phase and
amplitude distortions in the transmitted and received
wavefronts, heavily affecting image quality. To overcome this
problem, a large number of phase aberration correction
techniques have been developed [19], [20]. They usually
model the skull as a thin phase – or a phase and amplitude –
screen located in the near field of the transducer. The relative
temporal delays to apply to each transducer element are
calculated to correct the aberrations. Most techniques obtain
these delays using the correlation between signals received on
different elements. They then iteratively repeat the process to
increase the spatial coherence of the signals based on an
indicator such as the focus criterion [21] or speckle brightness
[22]. They can take advantage of a point-like scatterer if one
is present in the medium [23], [24], or use diffuse scatterers if
not. In particular, in the case of blood flow imaging, several
methods using moving scatterers have been developed [25],
[26]. Their implementation in the clinic however remains
challenging, and in the case of transcranial Doppler, is still
limited to the major brain vessels [27], [28].
In the particular case of transcranial ULM however, the
microbubbles not only compensate for the high attenuation of
the skull bone but also enable the correction of the strong skull
aberrations. Each micro-bubble can indeed be considered as a
point-like source conveniently placed behind the skull. This
microbubble can be used as a beacon for the recovery of the
skull bone aberration by providing an experimental estimation
of the Green’s function relating the microbubble position to
the piezoelectric elements of the ultrasonic array. The skull-
induced phase aberration profile, as well as the effective speed
of sound of the medium, can thus be derived by studying the
distortions in the wavefront coming from this beacon. This
technique, in a very preliminary form, was briefly mentioned
in the first proof of concept of transcranial ULM in human
[15]. In the present paper, we take this technique to an
accomplished level, giving extensive details about its
implementation, showing results both on contrast transcranial
Doppler and transcranial ULM images, and quantifying the
improvement on the images, for application in cerebro-
vascular imaging in human adults.
2. Materials and Methods
2..1 Clinical Protocol
All experiments strictly comply with the ethical principles
for medical research involving human subjects of the World
Medical Association Declaration of Helsinki. Healthy
volunteers and patients were recruited under the protocol
accepted by the CCER of Geneva (n° 2017-00353) and gave
informed and written consent. The dose of injected contrast
agent as well as the amplitude and duration of ultrasound
exposures were kept to the minimum enabling the ultrasound
localization microscopy to follow the ALARA (“As Low As
Reasonably Achievable”) principle. Ultrasound parameters
were well below the FDA recommendations (AUIM/NEMA
2004, Track 3) for ultrasound imaging, with a maximum
Mechanical Index (MI) of 0.46 (maximum FDA
recommended value is 1.9), a maximum derated Spatial Peak
Temporal Average Intensity (ISPTA) of 64.3mW/cm²
(maximum FDA recommended value 720mW/cm²), a
maximum Thermal Cranial Index (TIC) of 1.99 (FDA
regulations ask for explanations for values above 6). A widely
clinically used echo-contrast agent consisting of Sulphur
hexafluoride micro-bubbles with a mean diameter of 2.5 μm
and a mean terminal half-life of 12 min (SonoVue®, Bracco,
Italy) was injected intravenously via the cubital vein. Up to